Maintenance risankizumab sustains induction response in patients with Crohn’s disease in a randomized phase 3Trial
- Marc Ferrante*
- , Peter M. Irving
- , Maria T. Abreu
- , Jeffrey Axler
- , Xiang Gao
- , Qian Cao
- , Toshimitsu Fujii
- , Astrid Rausch
- , Joana Torres
- , Ezequiel Neimark
- , Alexandra Song
- , Kori Wallace
- , Kristina Kligys
- , Sofie Berg
- , Xiaomei Liao
- , Qing Zhou
- , Jasmina Kalabic
- , Brian Feagan
- , Remo Panaccione
*Corresponding author for this work
Research output: Contribution to journal › Article › peer-review
14
Citations
(Scopus)